DE602005020608D1 - NEISSERIA MENINGITIDIS IgtB LOS ALS ADJUVANS - Google Patents

NEISSERIA MENINGITIDIS IgtB LOS ALS ADJUVANS

Info

Publication number
DE602005020608D1
DE602005020608D1 DE602005020608T DE602005020608T DE602005020608D1 DE 602005020608 D1 DE602005020608 D1 DE 602005020608D1 DE 602005020608 T DE602005020608 T DE 602005020608T DE 602005020608 T DE602005020608 T DE 602005020608T DE 602005020608 D1 DE602005020608 D1 DE 602005020608D1
Authority
DE
Germany
Prior art keywords
los
igtb
adjuvans
less
neisseria meningitidis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005020608T
Other languages
English (en)
Inventor
Liana Juliana Steeghs
De Winkel Johannes Gerardus Van
Der Ley Peter Andre Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlanden Volksgezondheid Welzijn en Sport VWS
Original Assignee
Nederlanden Volksgezondheid Welzijn en Sport VWS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Volksgezondheid Welzijn en Sport VWS filed Critical Nederlanden Volksgezondheid Welzijn en Sport VWS
Publication of DE602005020608D1 publication Critical patent/DE602005020608D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Amplifiers (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Soft Magnetic Materials (AREA)
  • Steroid Compounds (AREA)
DE602005020608T 2004-05-11 2005-05-11 NEISSERIA MENINGITIDIS IgtB LOS ALS ADJUVANS Active DE602005020608D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04076401 2004-05-11
PCT/NL2005/000358 WO2005107798A1 (en) 2004-05-11 2005-05-11 NEISSERIA MENINGITIDIS IgtB LOS AS ADJUVANT

Publications (1)

Publication Number Publication Date
DE602005020608D1 true DE602005020608D1 (de) 2010-05-27

Family

ID=34928212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020608T Active DE602005020608D1 (de) 2004-05-11 2005-05-11 NEISSERIA MENINGITIDIS IgtB LOS ALS ADJUVANS

Country Status (18)

Country Link
US (1) US20080138359A1 (de)
EP (1) EP1748791B1 (de)
JP (1) JP5174457B2 (de)
KR (1) KR101270838B1 (de)
CN (1) CN1997392B (de)
AT (1) ATE464066T1 (de)
AU (1) AU2005239963B2 (de)
BR (1) BRPI0511026C1 (de)
CA (1) CA2566409C (de)
DE (1) DE602005020608D1 (de)
DK (1) DK1748791T3 (de)
ES (1) ES2344114T3 (de)
MX (1) MXPA06013093A (de)
NZ (1) NZ551250A (de)
PL (1) PL1748791T3 (de)
PT (1) PT1748791E (de)
SI (1) SI1748791T1 (de)
WO (1) WO2005107798A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
AR058592A1 (es) 2005-12-22 2008-02-13 Glaxosmithkline Biolog Sa Vacuna
NZ570805A (en) 2006-03-30 2011-10-28 Glaxosmithkline Biolog Sa Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
CN101883583B (zh) 2007-06-26 2017-05-17 葛兰素史密丝克莱恩生物有限公司 含有肺炎链球菌荚膜多糖缀合物的疫苗
US8642046B2 (en) * 2007-10-09 2014-02-04 Tufts University Cholera vaccines
NZ589812A (en) * 2008-05-30 2012-08-31 U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army Inst Of Res Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
CA2762033A1 (fr) * 2009-05-14 2010-11-18 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) et de proteine de neisseria meningitidis
AU2010247254A1 (en) 2009-05-14 2012-01-12 Sanofi Pasteur Menigococcus vaccine containing lipooligosaccharide (LOS) from modified strains of L6 immunotype Neisseria meningitidis
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
MX2012011189A (es) 2010-03-26 2013-02-07 Glaxosmithkline Biolog Sa Vacuna contra el virus e inmunodeficiencia humana.
EA201390452A1 (ru) 2010-09-27 2013-11-29 Глаксосмитклайн Байолоджикалс С.А. Вакцина
KR20120068647A (ko) * 2010-12-18 2012-06-27 아이진 주식회사 개선된 면역반응을 유도하는 백신
RS57267B1 (sr) 2011-07-07 2018-08-31 De Staat Der Nederlanden Vert Door De Minister Van Vws Postupak za proizvodnju vezikula spoljašnje membrane gram-negativne bakterije bez upotrebe deterdženta
GB201310008D0 (en) 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
AU2015359503B2 (en) 2014-12-10 2019-05-09 Glaxosmithkline Biologicals Sa Method of treatment
KR102002034B1 (ko) 2015-07-09 2019-07-22 에스에프씨주식회사 고효율과 장수명을 갖는 유기 발광 소자
EP3263695A1 (de) 2016-06-29 2018-01-03 GlaxoSmithKline Biologicals SA Immunogene zusammensetzungen
JP6963018B2 (ja) * 2016-10-31 2021-11-05 アイジーン インコーポレイテッドEyegene Inc. 免疫調節剤及びこれを含むワクチン組成物
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9101359A (nl) 1991-08-07 1993-03-01 Nederlanden Staat Nieuw saccharide-peptide-conjugaat, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk saccharide-peptide-conjugaat omvat.
AU762369B2 (en) * 1998-11-03 2003-06-26 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur LPS with reduced toxicity from genetically modified gram negative bacteria
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
EP1423142A1 (de) * 2001-08-31 2004-06-02 Chiron SRL. Helicobacter pylori impfung mit einer kombination der proteine caga, vaca und nap
JP2006500963A (ja) * 2002-08-02 2006-01-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
ATE450271T1 (de) * 2006-06-12 2009-12-15 Glaxosmithkline Biolog Sa Impfstoff

Also Published As

Publication number Publication date
CN1997392A (zh) 2007-07-11
CA2566409C (en) 2012-12-04
ATE464066T1 (de) 2010-04-15
CA2566409A1 (en) 2005-11-17
PL1748791T3 (pl) 2010-08-31
WO2005107798A1 (en) 2005-11-17
DK1748791T3 (da) 2010-06-28
BRPI0511026B1 (pt) 2019-01-08
KR101270838B1 (ko) 2013-07-04
BRPI0511026A (pt) 2007-11-27
JP5174457B2 (ja) 2013-04-03
JP2007537248A (ja) 2007-12-20
MXPA06013093A (es) 2007-08-08
EP1748791B1 (de) 2010-04-14
AU2005239963B2 (en) 2011-01-06
PT1748791E (pt) 2010-07-15
US20080138359A1 (en) 2008-06-12
ES2344114T3 (es) 2010-08-18
BRPI0511026B8 (pt) 2020-01-21
CN1997392B (zh) 2011-06-01
NZ551250A (en) 2010-03-26
AU2005239963A1 (en) 2005-11-17
EP1748791A1 (de) 2007-02-07
KR20070029742A (ko) 2007-03-14
BRPI0511026C1 (pt) 2021-05-25
SI1748791T1 (sl) 2010-07-30

Similar Documents

Publication Publication Date Title
DE602005020608D1 (de) NEISSERIA MENINGITIDIS IgtB LOS ALS ADJUVANS
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
UA95238C2 (uk) Імуногенна композиція
WO2006012209A3 (en) A new adjuvant composition
BRPI0510440A (pt) conjugados meningocócicos combinados com proteìna carreadora em comum
SG170127A1 (en) Vaccine compositions comprising a saponin adjuvant
AU2457100A (en) Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs
NO20031646L (no) Adjuvanssammensetning omfattende et immunostimulatorisk oligonukleotid og en tokol
MX2011012836A (es) Adyuvantes sinteticos de glucopiranosil-lipido.
WO2006120576A3 (en) Immunogens for meningitidis-a vaccines
DK2353608T3 (da) Polypeptid-vacciner til bred beskyttelse mod hypervirulente meningokok-linjer
NO20082716L (no) Sammensetninger og fremgangsmater for fremstilling av en sammensetning
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
NO20064781L (no) Fremgangsmater og adjuvanser for a forbedre immunresponser mot vaksiner og fremgangsmater for anvendelse
DE60303961D1 (de) Modifizierte saccharide, deren konjugate sowie deren herstellung
SE0201544D0 (sv) Novel compounds and thier use
EA200701128A1 (ru) Рекомбинантные штаммы bcg, обладающие повышенной способностью к высвобождению из эндосомы
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
BRPI0820960B8 (pt) composição, composição farmacêutica, e uso da composição
NO20034504D0 (no) Erytropoietin forbedrer in vivo kjemoterapiindusert toksisitet
DE502004011919D1 (de) -trien-3-yl sulfamate
DK1420757T3 (da) Kosmetiske mikroemulsioner indeholdende ectoin eller derivater
WO2004101737A3 (en) A novel adjuvant capable of specifically activating the adaptive immune response
MY127452A (en) Vaccines.
TH106356S (th) อุปกรณ์สอดใส่ในการปลูกถ่ายเนื้อเยื่อ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition